EconomicUnited States·30 Oct 2026
Eagle Pharmaceuticals Board Extends Stockholder Rights Plan
AI-summarized · Neutrality-checked
On October 30, 2026, the Board of Directors of Eagle Pharmaceuticals extended its existing stockholder rights plan by one year, setting a new expiration date of October 30, 2027. The Board implemented this amendment in response to significant dislocation in the trading price of the company's common stock. The plan is designed to deter unauthorized control…
Loading full story…
Sources and context
Business Insider Markets
Digital newsroomCompany ownedUnited StatesStandards not yet verified
Source-level context, not a score for this article. Methodology and evidence · Report outdated information
Know where. Know why.